Cannabigerol (CBG): the “Mother of All Cannabinoids”

While THC and CBD often steal the spotlight, another cannabinoid is gaining significant scientific attention: Cannabigerol, or CBG. Often referred to as the “mother of all cannabinoids,” CBG is a non-psychoactive compound that holds immense potential for various therapeutic applications. As research continues to unfold, CBG is emerging as a promising area for medical and wellness advancements, without the intoxicating effects associated with THC.

CBG’s designation as the “mother of all cannabinoids” stems from its role as the precursor to other major cannabinoids. In the cannabis plant, an acidic form called cannabigerolic acid (CBGA) is produced first. As the plant matures, or when exposed to heat, CBGA converts into various cannabinoids, including CBG, cannabidiolic acid (CBDA), and tetrahydrocannabinolic acid (THCA). These acidic forms then decarboxylate (lose a carboxyl group, often through heat) into their neutral, more commonly known forms like CBD and THC. This means that without CBG (or rather, CBGA), the plant wouldn’t be able to produce the wide array of cannabinoids we recognize.

Here are some key facts and scientific insights about CBG:

Non-Psychoactive:

• Explanation: Unlike THC, CBG does not produce the “high” or intoxicating effects. This makes it an attractive cannabinoid for those seeking therapeutic benefits without altered mental states.
• Source: Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives – PMC

Interactions with the Endocannabinoid System (ECS):

• Explanation: CBG interacts with the body’s endocannabinoid system, a complex network that helps regulate various physiological processes. While it doesn’t bind as strongly to the primary cannabinoid receptors (CB1 and CB2) as THC, it is believed to influence them in unique ways, potentially by blocking or enhancing the effects of other cannabinoids.
• Source: Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential – PMC

Potential Therapeutic Applications:

• Anti-inflammatory Properties: Studies suggest CBG may have strong anti-inflammatory effects, making it a subject of research for conditions like inflammatory bowel disease (IBD) and neuroinflammation.
• Neuroprotective Effects: Early research indicates CBG could offer neuroprotective benefits, potentially relevant for neurodegenerative disorders.
• Antibacterial Activity: CBG has shown promise as an antibacterial agent, including against antibiotic-resistant strains.
• Glaucoma Treatment: One of the earliest studied benefits of CBG is its potential to reduce intraocular pressure, which is beneficial for glaucoma.
• Appetite Stimulation: Some research points to CBG’s potential to stimulate appetite.
• Source: What Is CBG? Understanding Cannabigerol and Its Benefits – Medical Marijuana Doctors

Research & Studies (NIH & Others):

• Clinical Trials: The National Institutes of Health (NIH) is supporting research into cannabinoids, including CBG. For example, the “Veterans ECS21 (Exploring Cannabigerol for Sleep) Study” (NCT05088018) is a clinical trial investigating if CBG improves sleep for U.S. Veterans.

• Source: The Veterans ECS21 (Exploring Cannabigerol for Sleep) Study: A protocol for the first randomized clinical trial of Cannabigerol (CBG), a decentralized study designed for U.S. Veterans in California | medRxiv

• Efficacy and Safety Studies: Other studies registered with ClinicalTrials.gov, a database managed by the National Library of Medicine (part of NIH), are exploring the efficacy and safety of hemp-derived CBG in adults for various markers like inflammation and well-being (e.g., NCT05743985).

• Source: Efficacy and Safety of Hemp-derived, Full Spectrum Cannabigerol (CBG) in Adults – ClinicalTrials.gov

Legal Status in Michigan:

• Explanation: In Michigan, CBG derived from hemp (cannabis plants with less than 0.3% Delta-9 THC) is legal due to the 2018 Farm Bill, which federally legalized hemp and its derivatives. Michigan’s laws align with this federal framework for hemp products.

• Michigan Law (Indirectly): While there isn’t a specific MCL for CBG, its legality falls under the state’s broader cannabis regulations, which distinguish between hemp and marijuana based on THC content. The Michigan Regulation and Taxation of Marijuana Act (MRTMA) and the Michigan Medical Marihuana Act (MMMA) govern marijuana, while industrial hemp is regulated by the Michigan Department of Agriculture and Rural Development (MDARD).

• Source: Is Delta 9 Legal in Michigan? – nama CBD, Michigan Department of Agriculture and Rural Development (MDARD) – Industrial Hemp

Starting in 2025, the U.S. Department of Agriculture (USDA) will regulate industrial hemp farmers in Michigan.
Previously, the Michigan Department of Agriculture and Rural Development (MDARD) oversaw hemp production in Michigan through its state-specific program.

However, due to a decline in licensed hemp growers and program sustainability concerns, Michigan legislation shifted regulatory oversight to the USDA.

This change is expected to lower licensing fees for growers and potentially open up broader markets for Michigan hemp products under a uniform federal standard.

Meanwhile Back at the Newsstand…

More Posts